DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Barf T, Covey T, Izumi R. , et al.
Acalabrutinib (ACP-196): a covalent Bruton tyrosine kinase inhibitor with a differentiated selectivity and in vivo potency profile.
J Pharmacol Exp Ther 2017;
363 (02) 240-252
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.